[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Activin Receptor Type 1 Market Report 2018

January 2018 | 97 pages | ID: U2792434433EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Activin Receptor Type 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Activin Receptor Type 1 in these regions, from 2012 to 2022 (forecast).
United States Activin Receptor Type 1 market competition by top manufacturers/players, with Activin Receptor Type 1 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Blueprint Medicines Corp
  • Daiichi Sankyo Company Ltd
  • La Jolla Pharmaceutical Company
  • Oncodesign SA
  • Tolero Pharmaceuticals Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • LJPC-6417
  • TP-0184
  • Dipyridamole
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Alport Syndrome
  • Chronic Kidney Disease
  • Kidney Fibrosis
  • Obesity
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Activin Receptor Type 1 Market Report 2017

1 ACTIVIN RECEPTOR TYPE 1 OVERVIEW

1.1 Product Overview and Scope of Activin Receptor Type
1.2 Classification of Activin Receptor Type 1 by Product Category
  1.2.1 United States Activin Receptor Type 1 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Activin Receptor Type 1 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 LJPC-6417
  1.2.4 TP-0184
  1.2.5 Dipyridamole
  1.2.6 Others
1.3 United States Activin Receptor Type 1 Market by Application/End Users
  1.3.1 United States Activin Receptor Type 1 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Alport Syndrome
  1.3.3 Chronic Kidney Disease
  1.3.4 Kidney Fibrosis
  1.3.5 Obesity
  1.3.6 Others
1.4 United States Activin Receptor Type 1 Market by Region
  1.4.1 United States Activin Receptor Type 1 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Activin Receptor Type 1 Status and Prospect (2012-2022)
  1.4.3 Southwest Activin Receptor Type 1 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Activin Receptor Type 1 Status and Prospect (2012-2022)
  1.4.5 New England Activin Receptor Type 1 Status and Prospect (2012-2022)
  1.4.6 The South Activin Receptor Type 1 Status and Prospect (2012-2022)
  1.4.7 The Midwest Activin Receptor Type 1 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Activin Receptor Type 1 (2012-2022)
  1.5.1 United States Activin Receptor Type 1 Sales and Growth Rate (2012-2022)
  1.5.2 United States Activin Receptor Type 1 Revenue and Growth Rate (2012-2022)

2 UNITED STATES ACTIVIN RECEPTOR TYPE 1 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Activin Receptor Type 1 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Activin Receptor Type 1 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Activin Receptor Type 1 Average Price by Players/Suppliers (2012-2017)
2.4 United States Activin Receptor Type 1 Market Competitive Situation and Trends
  2.4.1 United States Activin Receptor Type 1 Market Concentration Rate
  2.4.2 United States Activin Receptor Type 1 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Activin Receptor Type 1 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACTIVIN RECEPTOR TYPE 1 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Activin Receptor Type 1 Sales and Market Share by Region (2012-2017)
3.2 United States Activin Receptor Type 1 Revenue and Market Share by Region (2012-2017)
3.3 United States Activin Receptor Type 1 Price by Region (2012-2017)

4 UNITED STATES ACTIVIN RECEPTOR TYPE 1 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Activin Receptor Type 1 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Activin Receptor Type 1 Revenue and Market Share by Type (2012-2017)
4.3 United States Activin Receptor Type 1 Price by Type (2012-2017)
4.4 United States Activin Receptor Type 1 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ACTIVIN RECEPTOR TYPE 1 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Activin Receptor Type 1 Sales and Market Share by Application (2012-2017)
5.2 United States Activin Receptor Type 1 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACTIVIN RECEPTOR TYPE 1 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Blueprint Medicines Corp
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Activin Receptor Type 1 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo Company Ltd
  6.2.2 Activin Receptor Type 1 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 La Jolla Pharmaceutical Company
  6.3.2 Activin Receptor Type 1 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Oncodesign SA
  6.4.2 Activin Receptor Type 1 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Tolero Pharmaceuticals Inc
  6.5.2 Activin Receptor Type 1 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 ACTIVIN RECEPTOR TYPE 1 MANUFACTURING COST ANALYSIS

7.1 Activin Receptor Type 1 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Activin Receptor Type

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Activin Receptor Type 1 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Activin Receptor Type 1 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACTIVIN RECEPTOR TYPE 1 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Activin Receptor Type 1 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Activin Receptor Type 1 Sales Volume Forecast by Type (2017-2022)
11.3 United States Activin Receptor Type 1 Sales Volume Forecast by Application (2017-2022)
11.4 United States Activin Receptor Type 1 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Activin Receptor Type
Figure United States Activin Receptor Type 1 Market Size (K Pcs) by Type (2012-2022)
Figure United States Activin Receptor Type 1 Sales Volume Market Share by Type (Product Category) in 2016
Figure LJPC-6417 Product Picture
Figure TP-0184 Product Picture
Figure Dipyridamole Product Picture
Figure Others Product Picture
Figure United States Activin Receptor Type 1 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Activin Receptor Type 1 by Application in 2016
Figure Alport Syndrome Examples
Table Key Downstream Customer in Alport Syndrome
Figure Chronic Kidney Disease Examples
Table Key Downstream Customer in Chronic Kidney Disease
Figure Kidney Fibrosis Examples
Table Key Downstream Customer in Kidney Fibrosis
Figure Obesity Examples
Table Key Downstream Customer in Obesity
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Activin Receptor Type 1 Market Size (Million USD) by Region (2012-2022)
Figure The West Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Activin Receptor Type 1 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Activin Receptor Type 1 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Activin Receptor Type 1 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Activin Receptor Type 1 Sales Share by Players/Suppliers
Figure 2017 United States Activin Receptor Type 1 Sales Share by Players/Suppliers
Figure United States Activin Receptor Type 1 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Activin Receptor Type 1 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Activin Receptor Type 1 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Activin Receptor Type 1 Revenue Share by Players/Suppliers
Figure 2017 United States Activin Receptor Type 1 Revenue Share by Players/Suppliers
Table United States Market Activin Receptor Type 1 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Activin Receptor Type 1 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Activin Receptor Type 1 Market Share of Top 3 Players/Suppliers
Figure United States Activin Receptor Type 1 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Activin Receptor Type 1 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Activin Receptor Type 1 Product Category
Table United States Activin Receptor Type 1 Sales (K Pcs) by Region (2012-2017)
Table United States Activin Receptor Type 1 Sales Share by Region (2012-2017)
Figure United States Activin Receptor Type 1 Sales Share by Region (2012-2017)
Figure United States Activin Receptor Type 1 Sales Market Share by Region in 2016
Table United States Activin Receptor Type 1 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Activin Receptor Type 1 Revenue Share by Region (2012-2017)
Figure United States Activin Receptor Type 1 Revenue Market Share by Region (2012-2017)
Figure United States Activin Receptor Type 1 Revenue Market Share by Region in 2016
Table United States Activin Receptor Type 1 Price (USD/Pcs) by Region (2012-2017)
Table United States Activin Receptor Type 1 Sales (K Pcs) by Type (2012-2017)
Table United States Activin Receptor Type 1 Sales Share by Type (2012-2017)
Figure United States Activin Receptor Type 1 Sales Share by Type (2012-2017)
Figure United States Activin Receptor Type 1 Sales Market Share by Type in 2016
Table United States Activin Receptor Type 1 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Activin Receptor Type 1 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Activin Receptor Type 1 by Type (2012-2017)
Figure Revenue Market Share of Activin Receptor Type 1 by Type in 2016
Table United States Activin Receptor Type 1 Price (USD/Pcs) by Types (2012-2017)
Figure United States Activin Receptor Type 1 Sales Growth Rate by Type (2012-2017)
Table United States Activin Receptor Type 1 Sales (K Pcs) by Application (2012-2017)
Table United States Activin Receptor Type 1 Sales Market Share by Application (2012-2017)
Figure United States Activin Receptor Type 1 Sales Market Share by Application (2012-2017)
Figure United States Activin Receptor Type 1 Sales Market Share by Application in 2016
Table United States Activin Receptor Type 1 Sales Growth Rate by Application (2012-2017)
Figure United States Activin Receptor Type 1 Sales Growth Rate by Application (2012-2017)
Table Blueprint Medicines Corp Basic Information List
Table Blueprint Medicines Corp Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Sales Growth Rate (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Sales Market Share in United States (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Company Ltd Basic Information List
Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Revenue Market Share in United States (2012-2017)
Table La Jolla Pharmaceutical Company Basic Information List
Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales Growth Rate (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales Market Share in United States (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Revenue Market Share in United States (2012-2017)
Table Oncodesign SA Basic Information List
Table Oncodesign SA Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Sales Growth Rate (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Sales Market Share in United States (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Revenue Market Share in United States (2012-2017)
Table Tolero Pharmaceuticals Inc Basic Information List
Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales Growth Rate (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales Market Share in United States (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Activin Receptor Type
Figure Manufacturing Process Analysis of Activin Receptor Type
Figure Activin Receptor Type 1 Industrial Chain Analysis
Table Raw Materials Sources of Activin Receptor Type 1 Major Players/Suppliers in 2016
Table Major Buyers of Activin Receptor Type
Table Distributors/Traders List
Figure United States Activin Receptor Type 1 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Activin Receptor Type 1 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Activin Receptor Type 1 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Activin Receptor Type 1 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Activin Receptor Type 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Activin Receptor Type 1 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications